Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 28 02:58PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-4.23 Insider Own13.05% Shs Outstand30.81M Perf Week4.26%
Market Cap399.30M Forward P/E- EPS next Y-2.59 Insider Trans-0.09% Shs Float26.79M Perf Month17.18%
Income-104.48M PEG- EPS next Q-0.68 Inst Own59.51% Short Float / Ratio10.55% / 11.43 Perf Quarter-31.75%
Sales77.28M P/S5.17 EPS this Y25.59% Inst Trans-0.64% Short Interest2.83M Perf Half Y36.13%
Book/sh-1.36 P/B- EPS next Y27.33% ROA-64.87% Target Price39.00 Perf Year70.75%
Cash/sh4.81 P/C2.69 EPS next 5Y- ROE- 52W Range7.15 - 24.13 Perf YTD46.11%
Dividend- P/FCF- EPS past 5Y-17.60% ROI-181.54% 52W High-46.29% Beta0.99
Dividend %- Quick Ratio6.87 Sales past 5Y13121.31% Gross Margin87.92% 52W Low81.26% ATR0.68
Employees200 Current Ratio7.06 Sales Q/Q29.54% Oper. Margin-92.15% RSI (14)60.05 Volatility6.18% 5.22%
OptionableYes Debt/Eq- EPS Q/Q40.21% Profit Margin-135.20% Rel Volume0.46 Prev Close12.78
ShortableYes LT Debt/Eq- EarningsNov 14 BMO Payout- Avg Volume247.21K Price12.96
Recom1.40 SMA209.44% SMA500.82% SMA2003.13% Volume96,665 Change1.41%
Date Action Analyst Rating Change Price Target Change
Feb-08-23Downgrade Jefferies Buy → Hold $35 → $10
Apr-27-22Initiated Berenberg Buy $20
Apr-16-20Reiterated H.C. Wainwright Buy $53 → $57
Apr-13-20Reiterated H.C. Wainwright Buy $75 → $53
Jan-09-20Initiated National Securities Neutral $37
May-30-19Initiated JP Morgan Neutral
May-29-19Initiated Goldman Neutral
Jan-29-19Initiated H.C. Wainwright Buy $82
Nov-08-18Resumed Jefferies Buy
Apr-04-18Upgrade Raymond James Mkt Perform → Outperform
Nov-15-23 01:50PM
Nov-14-23 12:19PM
Nov-13-23 08:00AM
Nov-07-23 08:00AM
08:00AM Loading…
Oct-03-23 08:00AM
Sep-11-23 07:00AM
Sep-08-23 08:00AM
Aug-31-23 08:00AM
Aug-18-23 01:40PM
Aug-17-23 07:00AM
Aug-12-23 09:18AM
Aug-10-23 09:55AM
08:00AM Loading…
Aug-08-23 08:00AM
Aug-02-23 05:00PM
Aug-01-23 10:05AM
Jul-31-23 08:00AM
Jul-28-23 01:41PM
Jul-27-23 09:55AM
Jul-25-23 04:10PM
Jul-10-23 08:00AM
Jul-06-23 08:00AM
Jun-20-23 08:00AM
Jun-09-23 08:00AM
Jun-02-23 08:00AM
May-22-23 01:18PM
May-16-23 12:13PM
09:15AM Loading…
May-11-23 09:15AM
May-04-23 08:00AM
May-02-23 10:02AM
May-01-23 02:00PM
Apr-30-23 08:00AM
Apr-25-23 08:00AM
Apr-18-23 12:16PM
Mar-18-23 02:06AM
Mar-16-23 09:15AM
Mar-09-23 04:00PM
Mar-06-23 08:00AM
Mar-01-23 04:00PM
Feb-27-23 08:15AM
Feb-15-23 09:06AM
Feb-06-23 05:33AM
Jan-11-23 08:00AM
Jan-09-23 12:19PM
Dec-19-22 08:00AM
Dec-13-22 12:13PM
Dec-09-22 08:00AM
Dec-02-22 12:00PM
Dec-01-22 07:00PM
Nov-21-22 04:00PM
Nov-16-22 11:24AM
Nov-14-22 08:00AM
Nov-12-22 07:33AM
Nov-10-22 09:15AM
Nov-09-22 08:00AM
Nov-03-22 08:00AM
Oct-12-22 04:29AM
Oct-11-22 11:54AM
Sep-28-22 08:00AM
Sep-12-22 08:00AM
Sep-09-22 08:00AM
Sep-07-22 04:00PM
Aug-11-22 09:15AM
Jul-27-22 08:00AM
Jul-24-22 09:56AM
Jul-12-22 09:05AM
Jun-09-22 09:07AM
Jun-03-22 08:00AM
May-18-22 08:00AM
May-16-22 02:50PM
May-13-22 08:00AM
May-10-22 10:15AM
May-09-22 06:15PM
May-05-22 06:35PM
May-03-22 08:00AM
Mar-29-22 08:00AM
Mar-22-22 08:02AM
Mar-21-22 09:15AM
Mar-08-22 08:00AM
Mar-04-22 04:30PM
Mar-03-22 08:25AM
Mar-01-22 08:15AM
Feb-28-22 08:00AM
Feb-24-22 05:40PM
Feb-10-22 08:00AM
Feb-03-22 08:00AM
Jan-18-22 01:38PM
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Smith Jason DrewGeneral CounselAug 31Sale18.013,80068,43818,407Sep 05 04:28 PM
Schoenberg MarkChief Medical OfficerJan 31Sale10.121,90019,228146,879Feb 02 01:02 PM
Smith Jason DrewGeneral CounselJan 31Sale10.121,63616,55612,600Feb 02 01:04 PM
Schoenberg MarkChief Medical OfficerJan 20Option Exercise5.00122,677613,385146,627Jan 23 07:10 PM